---
company: AXCELIS TECHNOLOGIES INC
ticker: ACLS
form: 8-K
filed: 2026-05-07
accession: 0001104659-26-057147
source: https://www.sec.gov/Archives/edgar/data/1113232/000110465926057147/
---

# Axcelis Technologies (ACLS) earnings release, May 7, 2026

Axcelis Technologies Inc (ACLS) · Form 8-K, Item 2.02 · Filed 2026-05-07 · [SEC filing](https://www.sec.gov/Archives/edgar/data/1113232/000110465926057147/)

Axcelis Announces

Financial Results for First Quarter 2026

Q1 2026 Highlights:

BEVERLY, Mass., May 7, 2026— Axcelis

Technologies, Inc. (Nasdaq: ACLS) today announced financial results for the first quarter ended March 31, 2026.

President and CEO Russell Low commented, “We executed well in the first quarter, delivering results slightly above expectations, reflecting the strength of our CS&I business and meaningful acceleration in Memory. Demand in DRAM and HBM was again a clear highlight, with strong sequential growth building on our momentum exiting 2025. CS&I remains an area of focus for Axcelis and is becoming an increasingly important strategic driver of our business across cycles, particularly as our installed base expands.”

Low added, “We continue to anticipate 2026 revenue will be relatively flat compared to 2025, as growth in Memory is offset by a continued digestion of capacity in our Power and General Mature markets. That said, we are encouraged by our bookings activity in the first quarter and the robust customer engagement we are having across a wide array of opportunities, which positions Axcelis for increased momentum exiting 2026 and into 2027. We look forward to completing our merger with Veeco, which we expect to close in the second half of 2026.”

Senior Vice President and Interim CFO

David Ryzhik stated, “We ended the first quarter with a strong balance sheet, including approximately $570 million of cash, and continued to generate attractive free cash flow, providing ample flexibility to fund our growth objectives and maintain a value-creative capital allocation strategy. As we look to the balance of the year, we are well positioned to execute, supported by firming order trends, an anticipated increase in revenue in the second half, and continued investments in innovation to capture attractive opportunities ahead.”

Results

Summary

(In thousands, except per share amounts and percentages)

Business Outlook

For the second quarter ending June 30,

2026, Axcelis expects revenues of approximately $205 million, GAAP earnings per diluted share of approximately $0.57, and non-GAAP earnings per share of approximately $0.90.

Please refer to Second Quarter 2026

Outlook under the “Notes on our Non-GAAP Financial Information” section of this document for detail relating to the computation of non-GAAP earnings per diluted share as well as the Safe Harbor Statement section of this document.

First Quarter 2026 Conference Call

The Company will host a call to discuss the results for the first quarter 2026 today at 5:00 p.m. ET. The call will be available via webcast that can be accessed through the Investors page of Axcelis' website at www.axcelis.com, or by registering as a participant here: https://register-conf.media-server.com/register/BIabf144ee757c4fccaceea99cf3cea2c9

Webcast replays will be available for

30 days following the call.

Use of Non-GAAP Financial Results

This press release includes financial measures that are not presented in accordance with U.S. generally accepted accounting principles (“non-GAAP financial measures”).

These non-GAAP financial measures include non-GAAP gross profit, non-GAAP gross margin, non-GAAP operating income, non-GAAP operating margin, non-GAAP income tax provision, Adjusted EBITDA, non-GAAP net income, and non-GAAP diluted earnings per share, and reflect adjustments for the impact of share-based compensation expense, certain items related to restructuring and severance charges and any associated adjustments and transaction and integration costs associated with the merger agreement with Veeco Instruments announced on October 1, 2025.

Reconciliations of these non-GAAP financial measures to the most directly comparable financial measures calculated and presented in accordance with GAAP are provided in the financial tables included in this release. For further information regarding these non-GAAP financial measures, please refer to the tables presenting reconciliations of our non-GAAP results to our GAAP results and the “Notes on Our Non-GAAP Financial Information” at the end of this press release.

Safe Harbor Statement

This press release contains, and the conference call will contain, forward-looking statements under the Private Securities Litigation Reform Act safe harbor provisions. These statements, which include our expectations for spending in our industry and guidance for future financial performance, are based on management’s current expectations and should be viewed with caution. They are subject to various risks and uncertainties that could cause actual results to differ materially from those in the forward-looking statements, many of which are outside the control of the Company, including that customer decisions to place orders or our product shipments may not occur when we expect, that orders may not be converted to revenue in any particular quarter, or at all, whether demand will continue for the semiconductor equipment we produce or, if not, whether we can successfully meet changing market requirements, and whether we will be able to maintain continuity of business relationships with and purchases by major customers. Increased competitive pressure on sales and pricing, increases in material and other production costs that cannot be recouped in product pricing and instability caused by changing global economic, political or financial conditions, including with respect to the imposition of tariffs on our products or components of our products, could also cause actual results to differ materially from those in our forward-looking statements. These risks and other risk factors relating to Axcelis are described more fully in the most recent Form 10-K filed by Axcelis and in other documents filed from time to time with the Securities and Exchange Commission.

About Axcelis... (truncated)red in Beverly, Mass., has been providing innovative, high-productivity solutions for the semiconductor industry for over 45 years. Axcelis is dedicated to developing enabling process applications through the design, manufacture and complete life cycle support of ion implantation systems, one of the most critical and enabling steps in the IC manufacturing process. Learn more about Axcelis at www.axcelis.com.

CONTACTS:

Investor Relations Contact:

David Ryzhik

Senior Vice President and Interim CFO

Telephone: (978) 787-2352

Email:

David.Ryzhik@axcelis.com

Press/Media Relations Contact:

Maureen Hart

Senior Director, Corporate &

Marketing Communications

Telephone: (978) 787-4266

Email:

Maureen.Hart@axcelis.com

Axcelis Technologies, Inc.

Consolidated

Statements of Operations

(In thousands, except per share amounts)

(Unaudited)

Axcelis Technologies, Inc.

Consolidated

Balance Sheets

(In thousands, except per share amounts)

(Unaudited)

Axcelis

Technologies, Inc.

Condensed

Consolidated Statements of Cash Flows

(In thousands)

(Unaudited)

Notes on Our Non-GAAP Financial Information

Management uses non-GAAP gross profit, gross margin, operating income, operating margin, income tax provision, net income, diluted earnings per share, and Adjusted EBITDA to evaluate the Company’s operating and financial performance and for planning purposes. Axcelis believes these measures enhance an overall understanding of its performance and investors’ ability to review the Company’s business from the same perspective as the Company’s management.

There are limitations in using non-GAAP financial measures because the non-GAAP financial measures are not prepared in accordance with GAAP, may be different from non-GAAP financial measures used by other companies, and may exclude certain items that may have a material impact upon our reported financial results. The presentation of this additional information is not meant to be considered in isolation or as a substitute for the directly comparable financial measures prepared in accordance with GAAP.

Totals presented may not sum and percentages may not recalculate using figures presented due to rounding.

Axcelis

Technologies, Inc.

Schedule Reconciling

Selected Non-GAAP Financial Measures

(In thousands, except per share amounts and percentages)

Note

1: Restructuring and other costs primarily related to early retirement programs and severance costs, due to global cost-saving initiatives.

Note

2: Impact of taxes from non-GAAP adjustments, uses adjusted tax rate of 14%.

Note

3: Transaction and integration costs include expenses associated with the merger agreement with Veeco Instruments.

Note

4: First quarter 2025 transaction and integration costs includes $481,000 of expenses that were not reflected as a GAAP to Non-GAAP reconciliation line item when the Company reported first quarter 2025 results, given that this occurred prior to the transaction announcement on October 1, 2025.

Axcelis

Technologies, Inc.

Reconciliation of Net Income to Adjusted EBITDA

(In thousands, except percentages)

Note

1: Restructuring and other costs primarily related to early retirement programs and severance costs, due to global cost-saving initiatives.

Note

2: Transaction and integration costs include expenses associated with the merger agreement with Veeco Instruments.

Note

3:

First quarter 2025 transaction and integration costs include $481,000 of expenses that were not reflected as a GAAP to

Non-GAAP reconciliation line item when the Company reported first quarter 2025 results, given that this occurred prior to the transaction announcement on October 1, 2025.

Axcelis Technologies, Inc.

Second

Quarter Outlook

GAAP to Non-GAAP Diluted Earnings Per Share

Note

1: Transaction and integration costs include expenses associated with the merger agreement with Veeco Instruments.

Note

2: Impact of taxes from non-GAAP adjustments, uses adjusted tax rate of 14%.

Figures may not sum due to rounding.

## Financial statements

### Income Statement (Three months ended March 31, — (In thousands, except per share amounts and percentages))

| | Three months ended March 31, – 2026 | Three months ended March 31, – 2025 |
|---|---:|---:|
| Revenue | 198,956 | 192,563 |
| Gross margin | 40.5% | 46.1% |
| Operating margin | 4.0% | 15.1% |
| Net income | 9,214 | 28,579 |
| Diluted earnings per share | 0.3 | 0.88 |
| Non-GAAP Results | Non-GAAP gross margin | 40.7% | 46.4% |
| Non-GAAP Results | Non-GAAP operating margin | 11.7% | 18.5% |
| Non-GAAP Results | Adjusted EBITDA | 27,748 | 40,001 |
| Non-GAAP Results | Non-GAAP net income | 22,425 | 34,197 |
| Non-GAAP Results | Non-GAAP diluted earnings per share | 0.72 | 1.06 |

### Income Statement (Three months ended March 31, — (Unaudited) (in thousands))

| | Three months ended March 31, – 2026 | Three months ended March 31, – 2025 |
|---|---:|---:|
| Revenue: | Product | 188,008 | 182,824 |
| Revenue: | Services | 10,948 | 9,739 |
| Revenue: | Total revenue | 198,956 | 192,563 |
| Cost of revenue: | Product | 105,735 | 94,500 |
| Cost of revenue: | Services | 12,640 | 9,295 |
| Cost of revenue: | Total cost of revenue | 118,375 | 103,795 |
| Cost of revenue: | Gross profit | 80,581 | 88,768 |
| Operating expenses: | Research and development | 28,516 | 27,128 |
| Operating expenses: | Sales and marketing | 17,354 | 15,124 |
| Operating expenses: | General and administrative | 26,761 | 17,357 |
| Operating expenses: | Total operating expenses | 72,631 | 59,609 |
| Operating expenses: | Income from operations | 7,950 | 29,159 |
| Other income (expense): | Interest income | 4,462 | 5,601 |
| Other income (expense): | Interest expense | -1,292 | -1,367 |
| Other income (expense): | Other, net | -495 | -309 |
| Other income (expense): | Total other income | 2,675 | 3,925 |
| Other income (expense): | Income before income taxes | 10,625 | 33,084 |
| Other income (expense): | Income tax provision | 1,411 | 4,505 |
| Other income (expense): | Net income | 9,214 | 28,579 |
| Net income per share: | Basic | 0.3 | 0.89 |
| Net income per share: | Diluted | 0.3 | 0.88 |
| Shares used in computing net income per share: | Basic weighted average shares of common stock | 30,723 | 32,258 |
| Shares used in computing net income per share: | Diluted weighted average shares of common stock | 30,980 | 32,335 |

### Income Statement (Three months ended March 31, — (In thousands, except per share amounts and percentages))

| | Three months ended March 31, – 2026 | Three months ended March 31, – 2025 |
|---|---:|---:|
| GAAP gross profit | 80,581 | 88,768 |
| Restructuring1 |  | 226 |
| Stock-based compensation | 442 | 353 |
| Non-GAAP gross profit | 81,023 | 89,347 |
| Non-GAAP gross margin | 40.7% | 46.4 |
| Operating expenses | 72,631 | 59,609 |
| Transaction and integration3,4 | -10,398 | -481 |
| Bad debt expense | -65 |  |
| Restructuring1 |  | -923 |
| Stock-based compensation | -4,457 | -4,550 |
| Non-GAAP operating expenses | 57,711 | 53,655 |
| GAAP operating income | 7,950 | 29,159 |
| Transaction and integration3,4 | 10,398 | 481 |
| Bad debt expense | 65 |  |
| Restructuring1 |  | 1,149 |
| Stock-based compensation | 4,899 | 4,903 |
| Non-GAAP operating income | 23,312 | 35,692 |
| Non-GAAP operating margin | 11.7% | 18.5 |
| GAAP income tax provision | 1,411 | 4,505 |
| Income tax effect of non-GAAP adjustments2 | 2,151 | 915 |
| Non-GAAP income tax provision | 3,562 | 5,420 |
| GAAP net income | 9,214 | 28,579 |
| Transaction and integration3,4 | 10,398 | 481 |
| Bad debt expense | 65 |  |
| Restructuring1 |  | 1,149 |
| Stock-based compensation | 4,899 | 4,903 |
| Income tax effect of non-GAAP adjustments2 | -2,151 | -915 |
| Non-GAAP net income | 22,425 | 34,197 |
| GAAP diluted EPS | 0.3 | 0.88 |
| Transaction and integration3,4 | 0.34 | 0.01 |
| Restructuring1 |  | 0.04 |
| Stock-based compensation | 0.16 | 0.15 |
| Income tax effect of non-GAAP adjustments2 | -0.07 | -0.03 |
| Non-GAAP diluted EPS | 0.72 | 1.06 |

### Balance Sheet (December 31, — (Unaudited) (in thousands))

| | March 31, – 2026 | December 31, – 2025 |
|---|---:|---:|
| Current assets: | Cash and cash equivalents | 150,829 | 145,451 |
| Current assets: | Short-term investments | 215,771 | 228,802 |
| Current assets: | Accounts receivable, net | 161,814 | 168,479 |
| Current assets: | Inventories, net | 326,052 | 329,010 |
| Current assets: | Prepaid income taxes | 4,609 | 4,658 |
| Current assets: | Prepaid expenses and other current assets | 76,607 | 66,802 |
| Current assets: | Total current assets | 935,682 | 943,202 |
| Current assets: | Property, plant and equipment, net | 57,729 | 56,146 |
| Current assets: | Operating lease assets | 27,943 | 28,927 |
| Current assets: | Finance lease assets, net | 13,835 | 14,154 |
| Current assets: | Long-term restricted cash | 10,628 | 10,627 |
| Current assets: | Deferred income taxes | 80,514 | 79,895 |
| Current assets: | Long-term investments | 203,339 | 182,396 |
| Current assets: | Other assets | 44,874 | 46,004 |
| Current assets: | Total assets | 1,374,544 | 1,361,351 |
| Current liabilities: | Accounts payable | 51,558 | 42,309 |
| Current liabilities: | Accrued compensation | 16,663 | 34,233 |
| Current liabilities: | Warranty | 9,314 | 9,516 |
| Current liabilities: | Income taxes | 14,026 | 11,383 |
| Current liabilities: | Deferred revenue | 68,352 | 65,494 |
| Current liabilities: | Current portion of finance lease obligation | 1,648 | 1,575 |
| Current liabilities: | Other current liabilities | 42,353 | 33,150 |
| Current liabilities: | Total current liabilities | 203,914 | 197,660 |
| Current liabilities: | Long-term finance lease obligation | 40,310 | 40,754 |
| Current liabilities: | Long-term deferred revenue | 41,214 | 43,445 |
| Current liabilities: | Other long-term liabilities | 44,463 | 44,815 |
| Current liabilities: | Total liabilities | 329,901 | 326,674 |
| Stockholders’ equity: | Common stock, $0.001 par value, 75,000 shares authorized; 30,733 shares issued and outstanding at March 31, 2026; 30,717 shares issued and outstanding at December 31, 2025 | 31 | 31 |
| Stockholders’ equity: | Additional paid-in capital | 537,185 | 533,309 |
| Stockholders’ equity: | Retained earnings | 512,753 | 503,539 |
| Stockholders’ equity: | Accumulated other comprehensive loss | -5,326 | -2,202 |
| Stockholders’ equity: | Total stockholders’ equity | 1,044,643 | 1,034,677 |

### Cash Flow (Three months ended March 31, — (Unaudited) (in thousands))

| | Three months ended March 31, – 2026 | Three months ended March 31, – 2025 |
|---|---:|---:|
| Cash flows from operating activities | Net income | 9,214 | 28,579 |
| Adjustments to reconcile net income to net cash provided by operating activities: | Depreciation and amortization | 4,436 | 4,309 |
| Adjustments to reconcile net income to net cash provided by operating activities: | Stock-based compensation expense | 4,899 | 4,903 |
| Adjustments to reconcile net income to net cash provided by operating activities: | Other | 3,805 | -1,682 |
| Adjustments to reconcile net income to net cash provided by operating activities: | Change in operating assets and liabilities, net | -4,215 | 3,686 |
| Adjustments to reconcile net income to net cash provided by operating activities: | Net cash provided by operating activities | 18,139 | 39,795 |
| Cash flows from investing activities | Expenditures for property, plant and equipment and capitalized software | -1,839 | -4,960 |
| Cash flows from investing activities | Other changes in investing activities, net | -8,800 | 45,429 |
| Cash flows from investing activities | Net cash (used in) provided by investing activities | -10,639 | 40,469 |
| Cash flows from financing activities | Repurchase of common stock |  | -18,178 |
| Cash flows from financing activities | Other changes from financing activities, net | -1,397 | -1,932 |
| Cash flows from financing activities | Net cash used in financing activities | -1,397 | -20,110 |
| Cash flows from financing activities | Effect of exchange rate changes on cash and cash equivalents | -724 | 292 |
| Cash flows from financing activities | Net increase in cash, cash equivalents and restricted cash | 5,379 | 60,446 |
| Cash flows from financing activities | Cash, cash equivalents and restricted cash at beginning of period | 156,078 | 131,064 |
| Cash flows from financing activities | Cash, cash equivalents and restricted cash at end of period | 161,457 | 191,510 |
